Fortis Healthcare Q2 FY25 PAT up 5% at Rs. 193 Cr
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Revenue at Rs 3,623 crore, EBITDA at Rs 718 crore
Granules now has a total of 67 ANDA approvals from the USFDA
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
Lyka has received the CDSCO approval for manufacturing and marketing of Pregabalin Gel 8% w/w
This is used to treat central diabetes insipidus and bedwetting
Developed in consultation with clinicians and patients for an enhanced user experience
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
Subscribe To Our Newsletter & Stay Updated